As at Jan 21, 2025, the EXEL stock has a PE ratio of 23.06. This is based on the current EPS of $1.58 and the stock price of $36.43 per share. A decrease of 16% has been recorded in the P/E ratio compared to the average of 27.4 of the last 4 quarters.
The mean historical PE ratio of Exelixis over the last eight years is 57.25. The current 23.06 PE ratio is 60% below the historical average. In the past eight years, EXEL's PE ratio was at its highest in the Mar 2017 quarter at 722.33, with a price of $21.67 and an EPS of $0.03. The Dec 2018 quarter recorded the bottom point at 8.48, with a price of $19.67 and an EPS of $2.32.
Maximum annual increase: 235.44% in 2020
Maximum annual decrease: -85.49% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 36.91 | 31.17% |
2022 | 28.14 | 12.38% |
2021 | 25.04 | -55.09% |
2020 | 55.75 | 235.44% |
2019 | 16.62 | 95.99% |
2018 | 8.48 | -85.49% |
2017 | 58.46 | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
EXEL's current P/E ratio is lower than the 3, 5 and 10-year averages.
EXEL's PE ratio is lower than its peer stocks JNJ and PFE, but it is greater than MRK's. Exelixis's current PE ratio of 23.06 is below the average of its peers, which is 28.64.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 20.05 | $242.95B |
EXEL Exelixis Inc | 20.91 | $9.44B |
JNJ Johnson & Johnson | 23.96 | $347.78B |
PFE Pfizer Inc | 34.52 | $148.67B |
AMGN Amgen Inc | 34.79 | $147.53B |
BMY Bristol Myers Squibb Co | N/A | $115.91B |
CRIS Curis Inc | N/A | $28.28M |
EXEL stock has a price to earnings ratio of 23.06 as of Jan 21, 2025.
The 3-year average PE ratio for EXEL stock is 32.6.
The 5-year average PE ratio for EXEL stock is 38.6.
In the last eight years, the Mar 2017 quarter recorded the highest quarterly PE ratio at 722.33.
EXEL's current price to earnings ratio is 60% below its 8-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jan 21, 2025), Exelixis's stock price is $36.43. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.58. Therefore, Exelixis's P/E ratio for today is 23.06. PE RATIO(23.06) = STOCK PRICE($36.43) / TTM EPS($1.58)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.